Spravato® (Esketamine) & Ketamine Therapy

Professional Psychiatry Tailored to Your Unique Mental Health Needs

Spravato® & Ketamine Therapy: Innovative Treatments for Mental Health

Spravato® (Esketamine) and Ketamine Therapy represent breakthrough options in the treatment of certain mental health conditions, especially for individuals who have not responded adequately to traditional therapies.

What is Spravato®?

Spravato® is a prescription nasal spray containing esketamine, a derivative of ketamine. Approved by the FDA for treatment-resistant depression and depressive symptoms associated with major depressive disorder (MDD), Spravato® offers rapid relief for patients struggling with persistent depressive symptoms.

What is Ketamine Therapy?

Ketamine therapy uses low-dose intravenous (IV) or intramuscular (IM) ketamine infusions or nasal sprays to provide fast-acting antidepressant effects. Originally developed as an anesthetic, ketamine has gained attention for its unique mechanism targeting glutamate neurotransmission, promoting neuroplasticity and mood regulation.

Understanding Esketamine: The Science Behind Enhanced NMDA Receptor Targeting

Esketamine represents the S-enantiomer of racemic ketamine, demonstrating higher potency and selectivity as a noncompetitive NMDA receptor antagonist compared to its racemic counterpart. The S-ketamine enantiomer has a higher affinity for the NMDA receptor and is thought to produce fewer significant psychotomimetic effects, drowsiness, lethargy, or cognitive impairment than the R-ketamine enantiomer. This enhanced specificity allows esketamine to deliver more targeted therapeutic effects while potentially reducing unwanted side effects associated with traditional ketamine formulations.

The precise mechanism of action of esketamine in major depressive disorder is unknown, but the prevailing theory is that it preferentially blocks NMDA receptors on inhibitory γ-amino-butyric acid (GABA)-ergic interneurons. This blockade leads to an increase in extracellular glutamate, stimulating other receptors such as AMPA receptors, which promote neural communication and plasticity essential for mood regulation. By binding to NMDA receptors, esketamine enhances the release of glutamate, leading to the formation of new neural connections through a process known as synaptogenesis, helping restore neural circuits that are often impaired in individuals with depression.

Current evidence suggests that esketamine has a more direct stimulation effect on brain-derived neurotropic factor (BDNF) and mammalian target of rapamycin (mTOR) than present oral antidepressants. This enhanced neuroplasticity response may explain esketamine’s rapid onset of therapeutic effects and its ability to continue exhibiting benefits even after complete drug elimination, offering sustained improvements in treatment-resistant depression cases where conventional therapies have proven insufficient.

Spravato Treatment in Boston: Accessing Esketamine Therapy in the Greater Boston Area

For patients in the Boston metropolitan area seeking Spravato treatment, Global Behavioral Healthcare provides comprehensive esketamine therapy services designed to meet the unique needs of individuals with treatment-resistant depression. Our Boston-area Spravato treatment program combines the expertise of board-certified psychiatrists with state-of-the-art monitoring facilities to ensure safe and effective administration.

Esketamine treatment Boston requires specialized certification and monitoring protocols, which our facility maintains in full compliance with FDA requirements. Patients throughout greater Boston, including Cambridge, Somerville, Newton, and surrounding communities, can access our certified Spravato treatment center through both scheduled appointments and urgent care pathways for individuals experiencing severe depressive episodes or suicidal ideation.

Our Boston-based clinical team understands the specific challenges faced by patients in this high-pressure academic and professional environment, tailoring Spravato treatment protocols to accommodate the demanding schedules of students, healthcare workers, and business professionals while maintaining the strict safety and efficacy standards required for esketamine administration.

Who Can Benefit?

Spravato® and ketamine therapies are often considered when:

  • Depression or mood disorders have not improved with multiple antidepressant medications

  • Patients experience suicidal ideation requiring urgent symptom relief

  • Traditional therapies cause intolerable side effects or have limited effectiveness

How Does the Treatment Work?

  • Spravato®: Administered under medical supervision via a nasal spray, often alongside oral antidepressants. Patients remain under observation for at least two hours post-treatment to monitor safety and effectiveness.

  • Ketamine Therapy: Delivered in clinical settings through IV or IM infusions, with careful dosing and monitoring to ensure optimal outcomes and minimize side effects.

Both treatments help restore synaptic connections in the brain and promote rapid mood improvements, often within hours to days.

Benefits of Spravato® and Ketamine Therapy

  • Rapid symptom relief, sometimes within hours

  • Effective for treatment-resistant depression and certain anxiety disorders

  • Can reduce suicidal thoughts and improve overall mood and functioning

  • Provides an alternative for patients who have not responded to traditional medications

What to Expect During Treatment

  • Initial clinical evaluation to determine candidacy

  • Sessions typically last 40 minutes to an hour, including monitoring time

  • Possible mild side effects include dizziness, nausea, and dissociation, which usually resolve shortly after treatment

  • Treatment plans vary from several sessions over weeks to maintenance doses depending on clinical response

Safety and Monitoring

Spravato® and ketamine therapy are administered only in certified medical facilities with trained healthcare professionals to ensure patient safety. Continuous monitoring during and after treatment ensures prompt management of any side effects.

Conclusion: A New Frontier in Mental Health Care

Spravato® and ketamine therapy provide promising options for individuals with treatment-resistant depression and other complex mood disorders. These innovative therapies offer hope for rapid improvement and a better quality of life when conventional treatments have fallen short.

If you or a loved one are struggling with persistent depression or treatment-resistant symptoms, consult with a qualified healthcare provider to explore whether Spravato® or ketamine therapy could be right for you.

vivitrol, psychiatric practice, online mental health, trusted psychiatry, virtual mental health, mental health support, ketamine therapy, psychotherapy, psychiatric evaluation, conditions, holistic mental health, professional therapy, science and compassion, mental well-being, spravato, ketamine therapy, what is spravato, spravato treatment in boston, esketamine treatment in boston

Throughout the treatment process, clinicians providing Ketamine and Spravato® therapy offer continuous support and adjust treatment protocols as needed to promote sustained mental health improvement. They also educate patients and families about these innovative therapies, helping to reduce stigma and encourage active participation in the healing journey. By integrating medical treatment with therapeutic support, clinicians enhance the effectiveness of neurostimulation therapy and support long-term wellness.

Key responsibilities of clinicians providing Ketamine and Spravato® therapy include:

  • Comprehensive Assessment and Diagnosis: Evaluating the patient’s psychiatric history, symptom severity, and overall health to develop an individualized treatment plan.

  • Medication Management: Administering and monitoring Ketamine or Spravato® treatments, managing side effects, and adjusting dosage to optimize therapeutic response.

  • Psychotherapeutic Support: Coordinating or providing therapy to address underlying emotional and cognitive factors that contribute to mental health challenges.

  • Coordination of Care: Collaborating with psychiatrists, therapists, and primary care providers to ensure integrated, holistic treatment.

  • Ongoing Monitoring and Outcome Optimization: Continuously assessing patient progress, modifying treatment protocols as necessary, and equipping patients with tools and strategies to maintain improvements and prevent relapse.

Begin your path to healing with the compassionate care of our experienced psychiatric team.

We take the time to understand your unique needs and goals. Our team is here to support your growth—every step of the way.

Understanding depression is the first step toward reclaiming your mental and emotional well-being—explore how our care can help.

If anxiety is holding you back, we can help you develop effective coping strategies to regain control and peace.

Discover how ADHD treatment can improve focus, organization, and daily functioning—let's help you thrive.

Managing bipolar disorder involves personalized care plans—learn how we can support you in stabilizing mood swings.

Success Stories: Empowering Lives Through Compassionate Counseling

Patient Satisfaction Survey: Trusted by 98% of Our Patients to Deliver Meaningful Results